You are here: Industry Insights > recall

News List

AuroMedics Issues Voluntary Nationwide Recall of Pantoprazole Sodium for Injection 40 Mg per Vial americanpharmaceuticalreview
December 26, 2017
AuroMedics Pharma is voluntarily recalling one lot of Pantoprazole Sodium for Injection 40 mg per vial, to the hospital level.
Sanofi issues US-wide recall for arthritis product, after adverse events pharmafile
December 13, 2017
Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was noted that a particular batch was associated with unusually high levels of adverse events.
International Laboratories Issues Voluntary Recall of Pravastatin Sodium Tablets americanpharmaceuticalreview
August 14, 2017
The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets.
Lupin recalls 12,480 bottles of anti-depressant drug from US market expressbpd
July 20, 2017
The product is used for the treatment of depression, panic disorder and social anxiety disorder
Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of americanpharmaceuticalreview
June 22, 2017
Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction
Hospira Issues Voluntary Nationwide Recall for one Lot of 25% Dextrose Injection americanpharmaceuticalreview
April 27, 2017
Hospira is voluntarily recalling one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.
C.O. Truxton Issues Voluntary Nationwide Recall of Phenobarbital 15 mg Tablets Due to Labeling Error americanpharmaceuticalreview
April 24, 2017
C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, to the consumer/user level. The manufacturer received a confirmed customer complaint that a bottle labeled as phenobarbital 15 mg was found to contain phenobarbit
FDA Announces Nationwide Voluntary Recall of Hyland’s Teething Tablets americanpharmaceuticalreview
April 17, 2017
FDA has announced a nationwide voluntary recall of all lots of Hyland’s Baby Teething Tablets and Hyland’s Baby Nighttime Teething Tablets from Standard Homeopathic Company.
Isomeric Pharmacy Solutions Issues Voluntary Nationwide Recall of All Sterile Compounded Products americanpharmaceuticalreview
April 10, 2017
packaged by Isomeric and that remain within expiry to the hospital/user level because of the US Food and Drug Administration’s concerns of a lack of sterility assurance.
Mylan Provides Update on Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector americanpharmaceuticalreview
April 06, 2017
Mylan announced that Meridian Medical Technologies has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors...

Previous page 1 2 3 4 5 6 7 8 Next page